Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Posaconazole

Severity: Moderate

Glecaprevir / pibrentasvir and Posaconazole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole may increase glecaprevir and pibrentasvir exposure, and the combination may also raise posaconazole levels. Clinically significant effects are not well characterized, but hepatic tolerability of the HCV regimen is the main concern.

What this interaction means in plain words

Glecaprevir / pibrentasvir and Posaconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Posaconazole inhibits CYP3A4 and P-gp, and glecaprevir and pibrentasvir inhibit P-gp, which may reduce efflux of each other's substrates.

What to do

Monitor liver function tests and for adverse effects of both agents. No empirical dose change is required.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Posaconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Posaconazole?

MediHelp rates the interaction as moderate. Glecaprevir / pibrentasvir and Posaconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Posaconazole may increase glecaprevir and pibrentasvir exposure, and the combination may also raise posaconazole levels. Clinically significant effects are not well characterized, but hepatic tolerability of the HCV regimen is the main concern.

How serious is the interaction between Glecaprevir / pibrentasvir and Posaconazole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver function tests and for adverse effects of both agents. No empirical dose change is required.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in